Aref Y, Fat SC, Ray E. Recent insights into the role of hormones during development and their functional regulation. Front Endocrinol (Lausanne). 2024;15:1340432.

Article  PubMed  Google Scholar 

Amorim T, Khiyami A, Latif T, Fazeli PK. Neuroendocrine adaptations to starvation. Psychoneuroendocrinology. 2023;157: 106365.

Article  CAS  PubMed  Google Scholar 

Refardt J, Atila C, Christ-Crain M. New insights on diagnosis and treatment of AVP deficiency. Rev Endocr Metab Disord. 2023. https://doi.org/10.1007/s11154-023-09862-w.

Article  PubMed  Google Scholar 

Stewart PM, Biller BM, Marelli C, Gunnarsson C, Ryan MP, Johannsson G. Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency. J Clin Endocrinol Metab. 2016;101:4843–50.

Article  CAS  PubMed  Google Scholar 

Baldeweg SE, Ball S, Brooke A, Gleeson HK, Levy MJ, Prentice M, et al. Society for endocrinology clinical guidance: inpatient management of cranial diabetes insipidus. Endocr Connect. 2018;7:G8-g11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yedinak C, Ross IL. Significant risk of COVID-19 and related-hospitalization among patients with adrenal insufficiency: a large multinational survey. Front Endocrinol (Lausanne). 2022;13:1042119.

Article  PubMed  Google Scholar 

Smans LC, Souverein PC, Leufkens HG, Hoepelman AI, Zelissen PM. Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. Eur J Endocrinol. 2013;168:609–14.

Article  CAS  PubMed  Google Scholar 

Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM, et al. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol. 2017;176:471–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010;162:597–602.

Article  CAS  PubMed  Google Scholar 

Nielsen EH, Lindholm J, Laurberg P. Excess mortality in women with pituitary disease: a meta-analysis. Clin Endocrinol (Oxf). 2007;67:693–7.

Article  CAS  PubMed  Google Scholar 

Jasim S, Alahdab F, Ahmed AT, Tamhane S, Prokop LJ, Nippoldt TB, et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2017;56:33–42.

Article  CAS  PubMed  Google Scholar 

Attanasio AF, Mo D, Erfurth EM, Tan M, Ho KY, Kleinberg D, et al. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab. 2010;95:74–81.

Article  CAS  PubMed  Google Scholar 

Rosén T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. The Lancet. 1990;336:285–8.

Article  Google Scholar 

Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. Lancet. 2001;357:425–31.

Article  CAS  PubMed  Google Scholar 

Bates AS, Van’t Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169–72.

CAS  PubMed  Google Scholar 

Johannsson G, Ragnarsson O. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy? J Intern Med. 2021;290:1180–93.

Article  CAS  PubMed  Google Scholar 

Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol (Oxf). 2001;55:209–16.

Article  CAS  PubMed  Google Scholar 

Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf). 1999;50:457–64.

Article  CAS  PubMed  Google Scholar 

Sartorio A, Cattaneo M, Bucciarelli P, et al. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. 2000;108:486–92.

Kargi AY, Merriam GR. Diagnosis and treatment of growth hormone deficiency in adults. Nat Rev Endocrinol. 2013;9:335–45.

Article  CAS  PubMed  Google Scholar 

Vahl N, Jørgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol. 1997;272:E1108-1116.

CAS  PubMed  Google Scholar 

Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone-deficient adults are insulin-resistant. Metabolism. 1995;44:1126–9.

Article  CAS  PubMed  Google Scholar 

Hepprich M, Ebrahimi F, Christ E. Dyslipidaemia and growth hormone deficiency - A comprehensive review. Best Pract Res Clin Endocrinol Metab. 2023;37: 101821.

Article  CAS  PubMed  Google Scholar 

Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb Haemost. 1996;76:422–8.

Article  CAS  PubMed  Google Scholar 

Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH–an update. J Clin Endocrinol Metab. 2014;99:18–29.

Article  CAS  PubMed  Google Scholar 

Widdowson WM, Gibney J. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis. Clin Endocrinol (Oxf). 2010;72:787–92.

Article  CAS  PubMed  Google Scholar 

Miljic D, Popovic V. Metabolic Syndrome in Hypopituitarism. Front Horm Res. 2018;49:1–19.

Article  CAS  PubMed  Google Scholar 

Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, et al. The australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 1998;83:107–16.

CAS  PubMed  Google Scholar 

Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S, et al. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults. J Clin Endocrinol Metab. 2002;87:2725–33.

Article  CAS  PubMed  Google Scholar 

Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth hormone research society scientific committee. J Clin Endocrinol Metab. 1998;83:382–95.

Article  CAS  PubMed  Google Scholar 

Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab. 2012;97:E1938-1942.

Article  CAS  PubMed  Google Scholar 

Debono M, Ross RJ, Newell-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol. 2009;160:719–29.

Article  CAS  PubMed